8-KThe WireRed Alert
Executive Change · Shareholder Vote
Filed May 10, 2024 · 2y ago · Accession 0001558370-24-007697
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing text
View original ↗UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 9, 2024
Owens & Minor, Inc .
(Exact name of registrant as specified in its charter)
Virginia
001-09810
54-1701843
(State or other jurisdiction of
(Commission
(I.R.S. Employer
incorporation or organization)
File Number)
Identification No.)
9120 Lockwood Boulevard ,
Mechanicsville , Virginia
23116
(Address of principal executive
offices)
(Zip Code)
Post Office Box 27626,
Richmond, Virginia
23261-7626
(Mailing address of principal
executive offices)
(Zip Code)
Registrant’s telephone number, including area code (804) 723-7000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $2 par value per share
OMI
New York Stock Exchange
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.below):
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On May 9, 2024 at the 2024 Annual Meeting of Shareholders (the “Annual Meeting”) of Owens & Minor, Inc. (the “Company”), the shareholders approved Amendment No. 1 (the “Amendment”) to the Owens & Minor, Inc. 2023 Omnibus Incentive Plan (the “2023 Plan”). The description of the Amendment included in the Company's proxy statement filed with the Securities and Exchange Commission on March 27, 2024 is incorporated herein by reference.
Under the terms of the 2023 Plan, as amended by the Amendment, the Board of Directors (the “Board”) has authorized the Our People & Culture Committee of the Board to grant equity and other incentive awards to employees, non-employee directors and consultants. Each equity grant made pursuant thereto will be evidenced by an agreement between the Company and the person named therein.
Item 5.07 Submission of Matters to a Vote of Security Holders.
At the Company’s Annual Meeting on May 9, 2024, the matters described below were voted upon and approved as indicated. There were 76,598,351 shares of common stock entitled to vote at the meeting and 70,719,273 shares were voted in person or by proxy (approximately 92.32 % of shares entitled to vote).
(1) Election of nine directors, each for a one-year term, as follows:
Director
Votes For
Votes Against
Abstentions
Broker
Non- Votes
Mark A. Beck
66,891,207
684,202
30,087
3,113,777
Gwendolyn M. Bingham
66,827,630
753,451
24,415
3,113,777
Kenneth Gardner-Smith
67,076,877
496,810
31,809
3,113,777
Robert J. Henkel
67,012,152
560,864
32,480
3,113,777
Rita F. Johnson-Mills
66,918,229
661,973
25,294
3,113,777
Stephen W. Klemash
67,347,354
208,945
49,197
3,113,777
Teresa L. Kline
67,234,485
345,544
25,467
3,113,777
Edward A. Pesicka
67,351,295
220,911
33,290
3,113,777
Carissa L. Rollins
67,234,922
345,316
25,258
3,113,777
(2) Ratification of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024 as follows:
Votes
Votes For
Votes Against
Abstentions
Broker
Non- Votes
69,207,654
1,471,594
40,025
-
(3) Approval of Amendment No. 1 to the Owens & Minor, Inc. 2023 Omnibus Incentive Plan, as follows:
Votes
Votes For
Votes Against
Abstentions
Broker
Non- Votes
64,181,423
3,371,256
52,817
3,113,777
(4) Advisory vote to approve the compensation of our named executive officers as follows:
Votes
Votes For
Votes Against
Abstentions
Broker
Non- Votes
66,163,767
1,381,531
60,198
3,113,777
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
OWENS & MINOR, INC.
Date: May 10, 2024
By:
/s/ Heath H. Galloway
Name:
Heath H. Galloway
Title:
Executive Vice President, General Counsel and Corporate Secretary
Filing details
- Company
- ACCENDRA HEALTH INC/VA/
- Ticker
- ACH
- CIK
- 75252
- Form type
- 8-K
- Filing date
- May 10, 2024
- Report date
- May 9, 2024
- Document
- tmb-20240509x8k.htm
- Size
- 208 KB